Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore

NCT04825262 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant Rejection
Kidney Transplant; Complications

Interventions

DRUG: Tacrolimus

Sponsor

Singapore General Hospital